The American Academy of Neurology had its annual meeting recently, where the newest in research is presented with the hope of better treatments. At this year's meeting, we heard a lot about updates of clinical trials we are all becoming familiar with:
Rituximab - the monoclonal antibody directed a...
- Font size
- Email This
- Bookmark
- Thank you for your input
- Save
- RSS
- Report Abuse
What the community is saying...
Friday Funnies and MS Reversed in Mice
Posted 08/14 Comments (4)
Did you read the news this week?
Multiple...
I suffer from Multiple Sclerosis and I am told that it is RRMS. Doesn't feel like relapsing or remitting as I lose function. It's a terrible thing to actually become jealous of someone's ability to walk. I am a registered nurse- and unable to work in my field because no one wants a nurse who cannot provide bedside care, much less has a progressive neurological disease! What I have right now is a living existence- not a life. If this drug works as well as the studies report, even half as well as reported, I for one am willing to risk the side effects in hope of maintaining what function I do have left.